DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Di Bona D, Fiorino I, Taurino M. et al.
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
Respir Med 2017;
130: 55-60
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.